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Background: In 2007 the Georgian government introduced a full state-subsidized Medical Insurance Program for
the Poor (MIP) to provide better financial protection and improved access for socially and financially disadvantaged
citizens. Studies evaluating MIP have noted its positive impact on financial protection, but find only a marginal
impact on improved access. To better assess whether the effect of MIP varies according to different conditions, and
to identify areas for improvement, we explored whether MIP differently affects utilization and costs among chronic
patients compared to those with acute health needs.
Methods: Data were collected from two cross-sectional nationally representative household surveys conducted in
2007 and in 2010 that examined health care utilization rates and expenditures. Approximately 3,200 households
were interviewed from each wave of both studies using a standardized survey questionnaire. Differences in health
care utilization and expenditures between chronic and acute patients with and without MIP insurance were
evaluated, using coarsened exact matching techniques.
Results: Among patients with chronic illnesses, MIP did not affect either health service utilization or expenditures
for outpatient drugs and reduction in provider fees. For patients with acute illnesses MIP increased the odds (OR =
1.47) that they would use health services. MIP was also associated with a 20.16 Gel reduction in provider fees for
those with acute illnesses (p = 0.003) and a 15.14 Gel reduction in outpatient drug expenditure (p = 0.013). Among
those reporting a chronic illness with acute episode during the 30 days prior to the interview, MIP reduced
expenditures on provider fees (B = -20.02 GEL) with marginal statistical significance.
Conclusions: Our findings suggest that the MIP may have improved utilization and reduce costs incurred by
patients with acute health needs, while chronic patients marginally benefit only during exacerbation of their
illnesses. This suggests that the MIP did not adequately address the needs of the aging Georgian population where
chronic illnesses are prevalent. Increasing MIP benefits, particularly for patients with chronic illnesses, should receive
priority attention if universal coverage objectives are to be achieved.
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Since the early 1990s, which saw the end of the Soviet
Union, and when Georgia declared independence, the
country has faced important challenges trying to provide
adequate health protection to a population confronting
unprecedented social and economic changes. Limited
public spending on health, largely due to a weak econ-
omy and a lack of fiscal flexibility shifted responsibility
for health care financing onto private households. While
the Georgian government officially declared universal
access to care for all in 1995, the public-funded benefit
package introduced at that time only included limited
preventive and curative services, without adequate finan-
cial means. As a consequence, by 1995 household out-
of-pocket payments in Georgia reached almost 80% of
total health expenditures, with the state contributing
only 20% [1]. Significant out-of-pocket costs at the point
of service created financial barriers to accessing services,
and contributed to reducingthe use of health services.
Hospital discharges for acute illnesses declined from
14% in 1989 to 7% in 2011, and annual outpatient con-
tacts plunged from 8.2 to 2.1. [2,3] At the same time the
population of Georgia was aging, and overall morbidity
increased, with an increase in the prevalence of chronic
conditions [4]. However, even though individuals de-
clined formal services, ‘self-treatment’ without a doctor’s
advice increased. Viewed as a cheaper option than visiting
a health care provider–especially by chronic patients—the
increase in self-medication was facilitated by weak en-
forcement of pharmaceutical regulations, thus enabling in-
dividuals to purchase prescription drugs from pharmacies
over the counter, without a prescription [5]. A 2010 study
revealed that approximately one in every five individuals
(20.8%) reported self-treatment as a substitute for acces-
sing the formal health system [6].
In 2007, the Government of Georgia created major
health care financing reforms. Rather than offering a
limited universal package of coverage for all, the new re-
forms would offer comprehensive insurance coverage
and fully subsidized insurance premiums to the poorest
groups, determined through proxy means testing. For
others, the state covered more narrowly defined
benefits–mainly for medical emergencies. After being
piloted in two geographical regions in 2007, the new
program–Medical Insurance for Poor (MIP) - was rolled
out nationwide in 2008. By the end of 2010 almost 21%
of the poor [7,8] were enrolled in the program.
The MIP benefit package included 1) urgent out-
patient and in-patient treatment, including diagnostic-
laboratory testsnecessary for determining the need for
hospitalization; 2) planned in-patient services, with an
annual insurance limit of 15,000 GEL (1 GEL ~ 0.6 $US),
excluding expenses for cosmetic and aesthetic surgery,
resort treatment, sexual disorders, infertility, treatmentabroad, sexually transmitted infections, HIV, and hepa-
titis C; 3) chemotherapy and radiation therapy within a
12,000 GEL annual limit; 4) out-patient visits and lim-
ited diagnostic and laboratory tests prescribed by the
family physician or general practitioner; 5) compensation
for childbirth delivery costs (up to 400 GEL); and 6) out-
patient prescription drugs from a predefined essential
drugs list and with an annual limit of 50 GEL and with
50% co-payment [9]. Coverage for outpatient drugs was
very restrictive and had a very low annual limit, espe-
cially for chronic patients (50 Gel, or approximately 30
USD) considering that the National Health Accounts
(NHA) estimated that approximately 196 Gel per capita
is spent annually for drugs.
Studies that have analysed the impact of the MIP pro-
gram over time [10,11] are almost unanimous in show-
ing that the scheme had a significant and positive
impact on reducing costs to patients, in particular for
those seeking ‘in-patient’ services. However, the overall
impact on formal health care service utilization by MIP-
covered individuals was found to be marginal (only a 2%
increase), although this average hides significant differ-
ences between utilization in Tbilisi (the capital) and in
the rest of the country. For Tbilisi residents a 12%
growth in overall utilization and a 7.6% increase for ‘in-
patient service’ use was registered, while outside the
capital the increase in service utilization for MIP benefi-
ciaries was negligible.
These studies have offered possible explanations for
the low impact of MIP on utilization, namely that the
benefit package was oriented towards inpatient vs. out-
patient services and that the coverage for outpatient
drug costs was very limited [9] and thus failed to reduce
barriers to access, particularly among patients with
chronic diseases that often require long-term, regular
out-patient care and medicine. The annual health care
expenditures among chronic disease patients in Georgia
is estimated at 411 Gel (245 USD), of which the largest
share is spent on drugs [12].
The objective of this study was to offer further evi-
dence that might explain the low impact of MIP on
health care utilization, drawing on Andersen’s model of
health service use [13]. Among other factors, Andersen’s
model identifies health care delivery system characteris-
tics such as the financial arrangements affecting the af-
fordability of care, as well as individual characteristics
such as age, gender and perceived health needs. With
this framework in mind, we explain why the MIP did not
have a more positive impact on utilization by exploring
the differences, if any, in utilization rates and associated
costs between MIP- and non-MIP-insured individuals
with chronic diseases compared to those with acute health
needs, while controlling for other factors that might affect
utilization. A second objective was to assess the
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impact of MIP on this behaviour.
Methods
Data
Data for this analysis were taken from the Government
of Georgia’s Health Utilization and Expenditure Survey
(HUES). The first baseline HUES was carried out in
May-June 2007, and a second survey was conducted in
June 2010. Both the 2007 and 2010 surveys used the
same instruments and methodology but sampled differ-
ent households. The HUES was conducted using nation-
ally representative samples of approximately 3200
households in each wave. The total sample of individuals
was 11,848 and 11,663 respectively for HUES 2007 and
2010. Response rates in the HUES surveys differed
slightly, from 95% in 2007 to 89% percent in 2010. The
survey questionnaire listed all household members and
asked about current and past episodes of illness and
whether these illnesses were acute or chronic. Among
other data, the HUES collected information on use of
health care services for reported illness and related
household out-of-pocket expenditures for all cases that
occurred in the 30-day period prior to the interview.
More details on sampling, survey methodology and
questionnaire are provided elsewhere [12]. The sample
of households used in the HUES in each year was the
same sample that had already been interviewed in the
Integrated Household Budget Survey (IHBS). This survey
is undertaken by the national office of statistics on a
quarterly basis to assess living standards and monitor
poverty, and for other statistical purposes. As a result,
data on expenditures, or consumption levels (as a proxy
for the level of income), were available for each house-
hold included in the HUES.
Variables used
The main outcomes of this analysis were i) self-reported
formal (i.e. excluding alternative medicine) outpatient
service utilization in the last 30 days (binary), ii) self-
reported self-treatment in the last 30 days (binary), iii)
self-reported total out-of-pocket expenditure for an out-
patient care on a provider level (provider fee) in the last
30 days (continuous) and iv) total out-of-pocket expen-
ditures for medicines for prescribed drugs and/or for
drugs purchased for the purposes of self-treatment in
the last 30 days (continuous) and related to illness and/
or a chronic condition.
For the purpose of this study, we analysed the effect of
MIP on outcome variables separately for (a) those with
chronic illnesses (e.g. hypertension, diabetes, etc.), (b)
those with acute illnesses (e.g. abdominal pain, common
cold, etc.) and (c) those with chronic illnesses that expe-
rienced an acute episode. An acute episode may havebeen due to complications of a chronic condition or not,
e.g. chest pain. Individuals with chronic illnesses were
defined as those who responded “yes” to the following
question: “Does [participant name] suffer from any
chronic disease–that is, one that has lasted more than
one year?”, but who did not report experiencing any
acute complication during the last 30 days prior to sur-
vey. This group included any patient with a communic-
able and/or non-communicable disease lasting longer
than 12 months. Individuals with an acute illness were
defined as those who responded with “no” to the above
question, but “yes” to the following question: “Has [par-
ticipant name] been sick in the last 30 days?” Individuals
who reported a chronic disease but then also responded
that they had been sick in the last 30 days were included
in the third group (i.e. chronic disease patients with
acute or chronic complications).Analysis
A crude comparison of the likelihood of using outpatient
services and mean monthly expenditure on health care
and drugs between MIP-insured patients and non-MIP
insured would ignore the fact that there may be other
characteristics of MIP or non-MIP patients that are driv-
ing health care expenditures and/or utilization, such as
the economic status of the patient’s household or the pa-
tient’s perception of the state of their health. In order to
account for this, we employed a ‘coarsened exact match-
ing’ (CEM) [14]. The CEM method is described in detail
[15,16], and has been used to analyse expenditures for
chronic disease in other research [17]. Similar to pro-
pensity score matching (PSM) or exact matching (EM),
CEM aims to control the potential confounding influ-
ence of ‘pre-treatment’ covariates on the outcome of
interest by matching ‘treatment’ cases with ‘non-treat-
ment’ cases. However, unlike other matching methods, it
compares observations from the treatment and non-
treatment groups that are approximately similar with re-
gard to those covariates. As such, CEM has an advantage
over other methods of matching observational data such
as propensity-score matching (PSM) and exact matching
(EM) in that it doesn’t require that the matched observa-
tions are balanced in terms of pre-treatment covariates
like PSM does, nor does it require matched observations
to be precisely similar in terms of these covariates as in
EM [14,17]. Instead, CEM ‘coarsens’ the pre-treatment
covariates into categories, based on their distribution, or
on natural or intuitive divisions [14,16]. In our case,
‘treatment’ cases are MIP-insured individuals, and ‘non-
treatment’ controls are non-MIP-insured individuals.
According to Andersen’s model of health services use
[13], the utilization of health services and self-treatment
are determined by individual predisposing characteristics
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for services (health status), enabling factors at the indi-
vidual level (health insurance and income/assets) and
factors at the community/contextual level (urban/rural
residence). Drawing on this model, we used CEM to ac-
count for the potential confounding influence of the fol-
lowing pre-treatment characteristics on individual health
care utilization and expenditures (category cut-points
are indicated in parentheses): i) age category 0-14 years
/15-44 years/45-64 years /65 and older); ii) sex (male/fe-
male); iii) marital status (currently married/other); iv)
level of education attained (less than high school educa-
tion/high or technical school education/college or higher
education); v) place of residence (urban/rural); vi) per-
ceived health status (excellent/very good/good/fair/poor/
very poor); vii) household size; viii) level of education
attained by head of household; ix)proportion of males
in the household; x)proportion of individuals over the
age of 65 in the household and xi) household con-
sumption tercile. To establish terciles, household
monthly consumption was converted into per capita
adult equivalent consumption after adjusting for econ-
omies of scale. Household monthly consumption was
obtained from an integrated household budget survey
linked with HUES. Households were distributed into
tercile groups, thus individuals reveal slightly different
distributions in these groups due to different house-
hold size. As recommended by Blackwell, et al. [15],
we used the weights produced by the CEM matching
procedure to account for the different number of
treated and control observations.
While we do not have an objective measure of ‘need’
for health care services in the HUES data, by matching
on perceived health status we attempted to control for
the effect of perceived need on health care service
utilization. We chose to combine data from 2007 and
2010 in order to increase our sample size and thus our
power to observe statistical differences. This meant we
also matched on year (2007 or 2010) and adjusted 2007
reported expenditures for inflation. After matching, we
used logistic regression to analyse the odds of out-
patient service utilization and self-treatment utilization
among individuals reporting chronic illness, acute ill-
ness, and chronic illness with an acute episode, with
and without MIP. We used linear regression to analyse
the difference in mean health care expenditure for a
case of reported illness, and expenditures on outpatient
medicines between MIP insured and non-MIP insured
among these three groups. In all regressions we
accounted for intra-group correlation at the household
level using the ‘vce (cluster)’ command in our Stata
model, which specifies that standard errors allow for
intragroup correlation and thus do not require that the
observations be independent.Ethics statement
Our manuscript was based on secondary analysis data of
the survey. Consequently, it does not require ethics
approval.Results
The characteristics of the subset of individuals reporting
chronic illness, acute illness, and chronic illness with
acute episode in our sample are outlined in Table 1 for
both 2007 and 2010, as well as for the pooled sample.
Roughly 35% of the population reported they suffered
from a chronic illness, and about 20% of these individ-
uals were covered by MIP. The highest proportion of
MIP-insured individuals was in the poorest income ter-
cile for both years, however roughly a third of non-MIP-
insured individuals were also in the poorest tercile (see
Table 1 for more details).
The prevalence of outpatient service utilization among
those reporting chronic illness (MIP insured and not),
those reporting acute illness (MIP insured and not) and
those reporting chronic illness with acute episode (MIP
insured and not), as well as the mean out-of-pocket ex-
penditure on a provider level and for medicines (self-
purchased or purchased based on a doctor’s advice) for
these groups are shown in Table 2. Crude analysis sug-
gests that formal outpatient service utilization and self-
treatment among chronic disease sufferers not reporting
any acute health episode during the 30 days prior to our
survey was roughly equal between MIP-insured and
-non-MIP individuals, and also this patient group (both
MIP-insured and not) was significantly less likely to ad-
minister self-treatment (4.4%, compared to those report-
ing only acute health problems or chronic conditions
with acute episode: 27.8% and 35.8% respectively). On
average MIP-insured individuals with a chronic illness
appeared to spend 20.9 GEL (approximately 10.61 USD)
less on health care providers, and 5.9 GEL less on drugs
compared to non-MIP insured. The same analysis
among those with acute illnesses suggests that MIP-
insured individuals spend 12.57 GEL less on average on
outpatient health care and 17.42 GEL less on outpatient
medicines than their non-MIP insured counterparts.
The CEM procedure resulted in a reduction in the
imbalance of covariates between our ‘treated’ (i.e MIP)
and ‘untreated’ (non-MIP) groups. The L1 statistic
used to measure imbalance was reduced from 0.68 be-
fore matching to 1.45 after matching [18]. From the
sample of 7,697 individuals reporting chronic illnesses
3,251 were successfully matched using our matching
equation. Of the 1,715 individuals reporting acute ill-
nesses, 632 were successfully matched, and of the
1,540 reporting chronic illnesses with acute episode,
712 were successfully matched. The results of our
Table 1 Characteristics of MIP-insured and non-MIP insured samples, HUES 2007 & 2010 and pooled sample
Variable 2007 2010 Pooled
MIP Non-MIP Total MIP Non-MIP Total MIP Non-MIP Total
Freq % Freq % Freq % Freq % Freq % Freq % Freq % Freq % Freq %
Total 1,392 13.7 9,163 86.3 10,555 100.0 2,529 21.9 8,957 78.1 11,486 100.0 4,178 17.8 19,333 82.2 23,511 100
Disease group
Chronic illness only 680 18.7 2,965 81.3 3,645 30.8 1,006 24.8 3,046 75.2 4,052 34.7 1,686 21.9 6,011 78.1 7,697 32.7
Acute illness only 130 13.2 855 86.8 985 8.3 152 20.8 578 79.2 730 6.3 282 16.4 1,433 83.6 1,715 7.3
Chronic illness with acute complication 152 19.0 649 81.0 801 6.8 238 32.2 501 67.8 739 6.3 390 25.3 1150 74.7 1,540 6.6
Gender
Male 737 45.3 4,913 48.1 5,650 47.7 1,187 46.6 4,363 47.9 5,550 47.6 1,924 17.2 9,276 82.8 11,200 47.6
Female 891 54.7 5,307 51.9 6,198 52.3 1,363 53.5 4,750 52.1 6,113 52.4 2,254 18.3 10,057 81.7 12,311 52.4
Age
0-14 263 16.2 1,809 17.7 2,072 17.5 456 17.9 1,559 17.1 2,015 17.3 719 17.2 3,368 17.4 4,087 17.4
15-44 578 35.5 4,476 43.8 5,054 42.7 920 36.1 3,775 41.4 4,695 40.3 1,498 35.9 8,251 42.7 9,749 41.5
45-64 311 19.1 2,257 22.1 2,568 21.7 576 22.6 2,417 26.5 2,993 25.7 887 21.2 4,674 24.2 5,561 23.7
65 and older 476 29.2 1,678 16.4 2,154 18.2 598 23.5 1,362 14.9 1,960 16.8 1,074 25.7 3,040 15.7 4,114 17.5
Education
No Education 61 3.97 228 2.42 289 2.63 58 2.42 120 1.44 178 1.66 249 6.0 1575 8.1 1,824 7.8
Less than high school 468 30.49 2,173 23.03 2,641 24.07 703 29.37 1,632 19.61 2335 21.79 2,047 49.9 7,821 40.5 9,868 42.0
High or technical school education 856 55.77 4,925 52.2 5,781 52.70 988 41.27 2,875 34.54 3863 36.05 1,517 36.6 5,990 31.0 7,507 32.0
College or higher education 150 9.77 2,109 22.35 2,259 20.59 645 26.94 3,696 44.41 4341 40.51 365 8.7 3,947 20.4 4,312 18.3
Marital status
Other 754 46.3 4,904 48.6 5,658 48.3 1,158 45.4 4,538 50.3 5,696 49.2 1,912 16.8 9,442 83.2 11,354 48.7
Currently Married 874 53.7 5,194 51.4 6,068 51.8 1,392 54.6 4,487 49.7 5,879 50.8 2,266 19.0 9,681 81.0 11,947 51.3
Perceived Health status
Very good, good or excellent 578 35.6 5,377 53.3 5,955 50.8 1,010 39.6 4,518 50.1 5,528 47.8 1,588 38.0 9,895 51.8 11,483 49.3
Fair 490 30.1 2,847 28.2 3,337 28.5 689 27.0 2,703 30.0 3,392 29.3 1,179 28.2 5,550 29.0 6,729 28.9
Poor or very poor 558 34.3 1,873 18.6 2,431 20.7 851 33.4 1,798 19.9 2,649 22.9 1,409 33.7 3,671 19.2 5,080 21.8
Residence
Rural 1,303 80.0 6,112 59.8 7,415 62.6 1,911 74.9 5,423 59.5 7,334 62.9 3,214 76.9 11,535 59.7 14,749 62.7















Table 1 Characteristics of MIP-insured and non-MIP insured samples, HUES 2007 & 2010 and pooled sample (Continued)
Consumption tercile of household (from IHS)
Poorest tercile 636 45.7 2,994 32.7 3,630 34.4 1,249 49.4 2,871 32.1 4,120 35.9 1,885 48.1 5,865 32.4 7,750 35.2
Middle tercile 432 31.0 3,057 33.4 3,489 33.1 806 31.9 3,014 33.6 3,820 33.3 1,238 31.6 6,071 33.5 7,309 33.2















Table 2 Health care utilization and expenditures (GEL) of individuals with chronic illness, acute illness and chronic
illness with acute complications, HUES 2007/2010 (1 GEL- 1.74 USD)
MIP Non-MIP All
Patients reporting chronic illness
Frequency % Frequency % Frequency %
OP* service utilization 196 11.6 676 11.2 872 11.3
Self-treatment 68 4.0 271 4.5 339 4.4
Mean SE Mean SE Mean SE
Total OOP** provider fees 81.50 8.06 102.40 4.85 97.74 4.18
Total OOP drug expenditures 44.31 6.68 51.69 4.46 50.08 3.77
Patients reporting acute illness
Frequency % Frequency % Frequency %
OP service utilization 182 64.5 883 61.6 1065 62.1
Self-treatment 75 36.2 401 28.0 476 27.8
Mean SE Mean SE Mean SE
Total OOP provider fees 59.31 3.41 86.46 3.60 80.23 2.91
Total OOP drug expenditures 22.73 2.63 45.77 3.21 40.62 2.56
Patients reporting chronic illness with acute complications
Frequency % Frequency % Frequency %
OP service utilization 251 64.4 685 59.6 936 60.8
Self-treatment 108 27.7 443 38.5 551 35.8
Mean SE Mean SE Mean SE
Total OOP provider fees 73.66 4.24 87.58 4.56 83.85 3.53
Total OOP drug expenditure 34.42 4.18 48.57 3.57 43.92 2.77
*OP = outpatient; **OOP = Out-of-Pocket.
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self-treatment and respective expenditures are shown
in Table 3.
After matching, MIP-insured individuals with
chronic illnesses did not have statistically significant
higher odds of using formal outpatient services com-
pared to non-MIP- insured individuals with a chronic
illness. Among those reporting a chronic illness, MIP
was associated with a 16.31 GEL (approx. 9.36 USD)
reduction in provider fees, and with a 9.61 Gel reduc-
tion in out-of-pocket spending on medicines. How-
ever, these results were not statistically significant. Of
those with an acute illness, MIP-insured individuals
had 1.47 times the odds of outpatient utilization (p =
0.005). MIP was associated with a 20.16 Gel reduction
in provider fees for those with acute illnesses (p =
0.003) and a 15.14 Gel reduction in outpatient drug
expenditure (p = 0.013). Among those reporting a
chronic illness with acute episode, MIP reduced ex-
penditures on provider fees (B = -20.02 GEL) with
marginal statistical significance, and reduced expendi-
tures on drugs by (B = - 12.02GEL), which was not sta-
tistically significant.Discussion
Our study offers several interesting findings. First, it high-
lights significant differences in health care utilization
behavior for patients reporting chronic illnesses (re-
gardless of MIP status) and those reporting an acute
health problem or chronic illness with acute episode
within the 30-day period prior to our survey. On aver-
age (before matching), patients reporting a chronic ill-
ness appeared 5.5 times less likely to seek formal
outpatient services and/or to self-treat when compared
with the other two groups. The factors determining
lower utilization among those with chronic illnesses
need further research to better understand possible bar-
riers to their health care utilization experienced by the
population with chronic health problems. While our
study did not look into these issues in detail, from the
literature [19] it is known that individuals with chronic
illnesses associate visiting a health care provider with
high out-of-pocket costs. This includes direct provider
fees and the cost of transportation as well as indirect
economic costs—for example loss of income due to ab-
senteeism from work, missing business appointments,
etc. Consequently, many factors could be at play in
Table 3 Matched regression results of MIP vs. Non-MIP individuals, HUES 2007/2010
OR/B Robust SE p-value Pseudo R2 Log likelihood Prob > chi2
Patients reporting chronic illness (N = 3251)
Outpatient service utilization OR = 1.08 0.14 0.557 0.0002 -1345.5572 0.5574
Self-treatment OR = 0.77 0.15 0.172 0.0017 -750.4796 0.1721
Total OOP provider fees (Gel) B = - 16.31 12.63 0.197 _ _ _
Total OOP drug expenditure (Gel) B = - 9.61 6.29 0.127 _ _ _
Patients reporting acute illness (N = 632)
Outpatient service utilization OR = 1.47 0.33 0.005 0.0053 -419.38164 0.0849
Self-treatment OR = 0.91 0.25 0.741 0.0003 -348.22169 0.7414
Total OOP provider fees (Gel) B = - 20.16 6.68 0.003 _ _ _
Total OOP drug expenditure (Gel) B = - 15.14 6.08 0.013 _ _ _
Patients reporting chronic illness with acute complication (N = 712)
Outpatient service utilization OR = 1.28 0.23 0.178 0.0025 -511.40943 0.1779
Self-treatment OR = 0.65 0.12 0.018 0.0077 -486.00092 0.0178
Total OOP provider fees (Gel) B = - 20.02 11.08 0.071 _ _ _
Total OOP drug expenditures B = - 12.02 8.47 0.155 _ _ _
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tients, and these require further research.
Secondly, an effective health insurance package would
be expected to reduce financial barriers and improve
utilization rates among patients with chronic illnesses,
but our findings suggest the contrary. After matching
various characteristics that might affect health care
utilization, our results show that for those reporting
chronic illnesses, MIP status did not have a statistically
significant effect on utilization, self-treatment or out-of-
pocket drug expenditures. One potential explanation for
this could be that the MIP did not offer enticing enough
coverage for the costs of health care and medicines
associated with chronic illnesses in order to impact
utilization within this group. Indeed, according to HUES
[12] in 2010 chronic patients faced, on average, 600 Gel
in annual recurrent costs for drugs, while annual allow-
able drug benefits under the MIP was only 50 Gel or 8%
of the annual recurrent costs for drugs usually spent by
a chronic patient in Georgia. Furthermore the 9.61 Gel
reduction (not statistically significant) in out-of-pocket
drug costs associated with MIP in our study was only
obtained by visiting a health professional and obtaining
a drug prescription, and may not have provided suffi-
cient financial relief relative to the administrative hur-
dles associated with accessing outpatient care under
MIP regulations. The reduction in out-of-pocket expen-
ditures for provider fees within this group (approxi-
mately 15 Gel) was also not statistically significant and
represented only 20% of the average out-of-pocket ex-
penditures on health care providers among non-MIP in-
sured chronic disease patients. Consequently, with the
current design, MIP financial benefits to chronic patients(for drug costs and a provider fees) seem marginal for
motivating patients’ access to formal outpatient health
services. It thus seems logical for chronic patients not to
seek formal care unless out-of-pocket costs for pre-
scribed drugs and for accessing a provider are signifi-
cantly reduced with MIP benefits. This argument could
be further supported by the fact that MIP had no influ-
ence on the self-treatment of chronic patients, which is
a widespread phenomenon in post-Soviet states. Self-
treatment is often used to avoid out-of-pocket costs,
which are a financial barrier to care [6]. Our findings
closely match those reported elsewhere when insurance
benefits are not tailored to the needs of chronic patients
and do not reduce financial costs related to care [19].
Thirdly, MIP had a much stronger impact on out-of-
pocket expenditures for provider fees and drugs among
those reporting acute illnesses. The reduction in pro-
vider fees associated with MIP in this group represented
roughly 1/3 of the average spending on providers and 1/
2 of the average spending on drugs for non-MIP insured
individuals with acute illnesses. The combined financial
impact resulting from a reduction in out-of-pocket ex-
penses (for providers and drugs) for patients with an
acute illness amounts to over 35.3 Gel or 28% of a per
capita monthly income, as reported by the National Stat-
istical Office of Georgia for 2010 [8]. This significant
savings suggests the MIP package of benefits for acute
illnesses offered greater financial benefits than for
chronic illnesses, and had the potential to explain the
higher rate of service utilization in this group.
Fourthly, MIP impact on increased utilization was not
statistically significant for chronic patients with acute
episode, however in this group MIP did result in a 20-
Gotsadze et al. BMC Health Services Research  (2015) 15:88 Page 9 of 10Gel reduction in provider fees (p = 0.071) and no effect
on out-of-pocket drug expenditures, while it reduced the
odds of self-treatment (p = 0.018). The latter might imply
that the MIP dissuades these patients from pursuing
self-treatment.
The literature is rich with evidence that the affordabil-
ity of care is an important determinant of health care
utilization. Taken together, our findings suggest that
MIP was successful in significantly improving health
care affordability for those with acute illnesses, and re-
duced the odds of self-treatment for those suffering from
chronic illnesses with an acute episode. However,the
package of benefits that was offered for chronic condi-
tions was not effective in increasing use or for improving
the affordability of care for those suffering from chronic
illnesses.
Some limitations must be taken into account when
interpreting our results. First, our findings are based on
self-reported illness and utilization, which are prone to re-
call bias. However, by using a relatively short recall period
(30 days) the HUES attempted to reduce this potential
bias. Second, inflation-adjusted prices were estimated
using a conservative approach by applying the overall
Consumer Price Index rather than a health-specific infla-
tion rate, which was significantly higher during the study
period 2007 through 2010. As a result, we may have
underestimated the reduction in health care costs associ-
ated with the MIP. However, including the survey year in
the matching criteria minimized the bias introduced by in-
flation. Lastly, CEM does not account for factors that
affect assignment to treatment and outcome but that can-
not be observed, therefore any hidden bias due to latent
variables may remain after matching [20].
Conclusions
Our findings provide evidence that MIP appeared effect-
ive for increasing the odds of using services and redu-
cing out-of-pocket costs for those with acute illnesses,
and for reducing the odds of self-treatment for those
with chronic illnesses suffering from an acute episode.
However, MIP had almost no impact on reducing
chronic patients’ drug costs, which are a significant ex-
penditure item for this group often resulting in cata-
strophic spending [21] and increasing their odds of
using formal health care services. Georgia, like many
other middle-income countries, is facing a demographic
and epidemiological transition in which its population is
living longer, and with increasingly chronic conditions
[22]. These diseases impose significant economic bur-
dens on patients and their households. Therefore, for
universal coverage to be successful it is essential to re-
duce this burden and improve access to care through
better-designed benefits offered to all, and especially to
those with chronic illnesses.Our findings are important for the Georgian govern-
ment, which made a policy decision in 2013 to expand
the state funded program beyond “the poor” and offer
similar benefits to all. In light of our findings it is likely
that the Georgian government’s stated objective of uni-
versal coverage will be achieved. However this will not
improve access to care for all citizens unless the depth
of state coverage for chronic patients is improved and
better-tailored to their needs, and especially with respect
to outpatient drug coverage.
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